Form 4 for CRL Charles River Laboratories
Accepted 2023-11-21 00:00:00 ET · period of report 2021-03-01 · accession 0001127602-23-028148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-21 | 2023-11-20 | CRL | Girshick Birgit | COO, Corp. Executive VP | P - Purchase | $187.82 | +1,322 | 44.4K | +3% | +$248.3K | |
| 2023-11-21 | 2021-03-01 | CRL | Girshick Birgit | COO, Corp. Executive VP | G - Gift | $0.00 | -350 | 28.7K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-20 | P | A | 1,322 | $187.82 | 44,449 | D | — | — | (F1) The total in column 5 reflects the ownership as of the date of the transaction. |
| 2 | Common | Common Stock | 2021-03-01 | G | D | 350 | $0.00 | 28,710 | D | — | — | (F1) The total in column 5 reflects the ownership as of the date of the transaction. |